First Time Loading...

HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 4.65 CAD Market Closed
Updated: May 3, 2024

HLS Therapeutics Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HLS Therapeutics Inc
Operating Income Peer Comparison

Comparables:
M
MNX

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
HLS Therapeutics Inc
TSX:HLS
Operating Income
-$11.8m
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Manitex Capital Inc
XTSX:MNX
Operating Income
-CA$965.4k
CAGR 3-Years
-41%
CAGR 5-Years
29%
CAGR 10-Years
N/A

See Also

What is HLS Therapeutics Inc's Operating Income?
Operating Income
-11.8m USD

Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's Operating Income amounts to -11.8m USD.

What is HLS Therapeutics Inc's Operating Income growth rate?
Operating Income CAGR 3Y
1%

Over the last year, the Operating Income growth was 13%. The average annual Operating Income growth rates for HLS Therapeutics Inc have been 1% over the past three years .